A detailed history of Avantax Advisory Services, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 5,344 shares of DXCM stock, worth $428,802. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,344
Previous 7,059 24.3%
Holding current value
$428,802
Previous $800,000 55.25%
% of portfolio
0.0%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$64.0 - $116.06 $109,760 - $199,042
-1,715 Reduced 24.3%
5,344 $358,000
Q2 2024

Aug 09, 2024

BUY
$110.31 - $140.45 $381,451 - $485,676
3,458 Added 96.03%
7,059 $800,000
Q1 2024

May 08, 2024

BUY
$114.22 - $140.1 $107,595 - $131,974
942 Added 35.43%
3,601 $499,000
Q4 2023

Feb 07, 2024

BUY
$75.49 - $124.16 $200,727 - $330,141
2,659 New
2,659 $329,000
Q4 2020

Jan 22, 2021

SELL
$78.0 - $104.5 $43,134 - $57,788
-553 Closed
0 $0
Q3 2020

Oct 14, 2020

BUY
$95.51 - $112.95 $52,817 - $62,461
553 New
553 $226,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.